What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Pharma Industry News Base editing 101: Is precision gene editing safer than CRISPR‑Cas9 for therapeutic use? Is base editing safer than CRISPR? See how Beam, Verve, and Prime are using non-cutting gene editing to raise the bar for precision and clinical safety. byPallavi MadhirajuSeptember 11, 2025